Marc Wehrli

11PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 31, 2025
CAR T-Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real-World Experiences From a Single Center on the Use of Radiotherapy.

J T Jutzi, J Wampfler, C Ionescu

|Jun 04, 2025
IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models.

Stefanie R Bailey, Hana N Takei, Giulia Escobar

|Feb 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma.

Matthew J Frigault, Ning Yao, Trisha R Berger

|Nov 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML.

Harrison J Silva, Grace Martin, Filippo Birocchi

|Jun 05, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics.

Felix Korell, Michael L Olson, Diego Salas-Benito

|May 23, 2024
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.

Matthew J Frigault, Charlotte E Graham, Trisha R Berger

Pageof 2

Frequent Collaborators

9 joint publications

Marcela V Maus

7 joint publications

Mark B Leick

4 joint publications

Michael C Kann

4 joint publications

Harrison Silva